Serum leptin levels are increased in both patients with NAFLD and in animal models of the disease and may be associated with the development of hepatocyte steatosis and its progression through OB-R (leptin receptor) activation of the PI3-K/Akt kinase pathway [70,71]. Here, LEP is linked to metabolic dysfunction-associated steatotic liver disease.